Brief: Immix Biopharma To Offer And Sell Up To $750 Million In Securities - SEC Filing
09/01/2026 23:18
Jan 9 (Reuters) - Immix Biopharma Inc IMMX.O: IMMIX BIOPHARMA INC - TO OFFER AND SELL UP TO $750 MILLION IN SECURITIES - SEC FILING Source text: [ID:n0001493152-26-001159] Further company coverage: IMMX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary